vs
Side-by-side financial comparison of BlackSky Technology Inc. (BKSY) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $35.2M, roughly 1.1× BlackSky Technology Inc.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -2.5%, a 38.4% gap on every dollar of revenue. On growth, BlackSky Technology Inc. posted the faster year-over-year revenue change (15.9% vs -10.9%). Over the past eight quarters, BlackSky Technology Inc.'s revenue compounded faster (20.5% CAGR vs -15.0%).
BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
BKSY vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $39.6M |
| Net Profit | $-868.0K | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | -11.8% | 32.5% |
| Net Margin | -2.5% | 35.9% |
| Revenue YoY | 15.9% | -10.9% |
| Net Profit YoY | 95.5% | 117.2% |
| EPS (diluted) | $0.04 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $39.6M | ||
| Q3 25 | $19.6M | $43.4M | ||
| Q2 25 | $22.2M | $43.4M | ||
| Q1 25 | $29.5M | $47.3M | ||
| Q4 24 | $30.4M | $44.4M | ||
| Q3 24 | $22.5M | $53.1M | ||
| Q2 24 | $24.9M | $53.1M | ||
| Q1 24 | $24.2M | $54.8M |
| Q4 25 | $-868.0K | $14.2M | ||
| Q3 25 | $-15.3M | $12.8M | ||
| Q2 25 | $-41.2M | $2.5M | ||
| Q1 25 | $-12.8M | $21.5M | ||
| Q4 24 | $-19.4M | $6.5M | ||
| Q3 24 | $-12.6M | $2.8M | ||
| Q2 24 | $-9.4M | $18.5M | ||
| Q1 24 | $-15.8M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -11.8% | 32.5% | ||
| Q3 25 | -85.8% | 36.6% | ||
| Q2 25 | -62.8% | 33.6% | ||
| Q1 25 | -40.5% | 51.1% | ||
| Q4 24 | -20.0% | 10.6% | ||
| Q3 24 | -58.7% | 26.1% | ||
| Q2 24 | -47.0% | 51.4% | ||
| Q1 24 | -54.7% | 44.6% |
| Q4 25 | -2.5% | 35.9% | ||
| Q3 25 | -78.2% | 29.6% | ||
| Q2 25 | -185.8% | 5.7% | ||
| Q1 25 | -43.4% | 45.4% | ||
| Q4 24 | -63.9% | 14.7% | ||
| Q3 24 | -55.8% | 5.3% | ||
| Q2 24 | -37.7% | 34.8% | ||
| Q1 24 | -65.2% | 34.2% |
| Q4 25 | $0.04 | $0.15 | ||
| Q3 25 | $-0.44 | $0.12 | ||
| Q2 25 | $-1.27 | $0.02 | ||
| Q1 25 | $-0.42 | $0.21 | ||
| Q4 24 | $-0.61 | $0.05 | ||
| Q3 24 | $-0.66 | $0.03 | ||
| Q2 24 | $-0.52 | $0.20 | ||
| Q1 24 | $-0.88 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $124.5M | $164.1M |
| Total DebtLower is stronger | $201.1M | $42.8M |
| Stockholders' EquityBook value | $94.9M | $248.3M |
| Total Assets | $386.2M | $380.4M |
| Debt / EquityLower = less leverage | 2.12× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.5M | $164.1M | ||
| Q3 25 | $146.5M | $127.4M | ||
| Q2 25 | $93.8M | $152.7M | ||
| Q1 25 | $75.8M | $132.1M | ||
| Q4 24 | $52.5M | $125.0M | ||
| Q3 24 | $63.2M | $137.4M | ||
| Q2 24 | $41.2M | — | ||
| Q1 24 | $35.4M | — |
| Q4 25 | $201.1M | $42.8M | ||
| Q3 25 | $195.1M | $21.1M | ||
| Q2 25 | $122.5M | $7.1M | ||
| Q1 25 | $115.3M | $6.9M | ||
| Q4 24 | $107.7M | $6.6M | ||
| Q3 24 | $98.8M | $823.2K | ||
| Q2 24 | $108.6M | — | ||
| Q1 24 | $85.0M | — |
| Q4 25 | $94.9M | $248.3M | ||
| Q3 25 | $91.1M | $248.0M | ||
| Q2 25 | $86.6M | $244.6M | ||
| Q1 25 | $88.8M | $226.4M | ||
| Q4 24 | $94.0M | $195.1M | ||
| Q3 24 | $110.3M | $205.0M | ||
| Q2 24 | $76.5M | $8.8M | ||
| Q1 24 | $81.7M | $9.0M |
| Q4 25 | $386.2M | $380.4M | ||
| Q3 25 | $380.9M | $321.4M | ||
| Q2 25 | $310.8M | $315.3M | ||
| Q1 25 | $284.9M | $284.6M | ||
| Q4 24 | $254.1M | $266.1M | ||
| Q3 24 | $245.5M | $296.5M | ||
| Q2 24 | $224.3M | $19.5M | ||
| Q1 24 | $210.1M | $19.8M |
| Q4 25 | 2.12× | 0.17× | ||
| Q3 25 | 2.14× | 0.09× | ||
| Q2 25 | 1.41× | 0.03× | ||
| Q1 25 | 1.30× | 0.03× | ||
| Q4 24 | 1.15× | 0.03× | ||
| Q3 24 | 0.90× | 0.00× | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | 1.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.3M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.3M | $52.0M | ||
| Q3 25 | $-39.0M | $-20.9M | ||
| Q2 25 | $-7.3M | $-8.3M | ||
| Q1 25 | $27.2M | $1.9M | ||
| Q4 24 | $-1.8M | $-7.3M | ||
| Q3 24 | $1.0M | $5.0M | ||
| Q2 24 | $-1.8M | $19.2M | ||
| Q1 24 | $-3.8M | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $-7.9M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BKSY
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
